Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Operating Expenses | 2,511 | 2,118 | 1,376 | 848 | 1,043 |
| Operating Income | -2,511 | -2,118 | -1,376 | -848 | -1,043 |
| Other Income | -1,882 | 2,865 | -6,042 | -7,512 | 12,792 |
| Pre-tax Income | -4,393 | 747 | -7,418 | -8,360 | 11,750 |
| Net Income Continuous | -4,393 | 747 | -7,418 | -8,360 | 11,750 |
| Net Income | $-4,393 | $747 | $-7,418 | $-8,360 | $11,750 |
| EPS Basic Total Ops | -0.13 | -0.17 | -1.24 | -1.23 | 2.12 |
| EPS Basic Continuous Ops | -0.08 | 0.08 | -1.09 | -1.23 | 1.84 |
| EPS Diluted Total Ops | -0.13 | -0.17 | -1.24 | -1.23 | 2.12 |
| EPS Diluted Continuous Ops | -0.08 | 0.08 | -1.09 | -1.23 | 1.84 |
| EPS Diluted Before Non-Recurring Items | -0.01 | 0.13 | -0.32 | -0.09 | -0.25 |
| EBITDA(a) | $-2,511 | $-2,118 | $-1,376 | $-848 | $-1,043 |